Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Business Wire•15/10/2026•08:32 ET
0
Key Highlights
- ➤Q3 2026 results scheduled for November 4 after market close
- ➤Earnings conference call set for 4:30 p.m. ET on November 4
- ➤Niagen Bioscience (NAGE) will provide a general business update
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Wednesday, November 4, 2026, at 4:30 p.m. ET to discuss its financial results for the third quarter, which ended September 30, 2026. The company will report the financial results in a press release after the close of regular stock market trading hours on Wednesday, November 4, 2026.
Get started
Create a free account to read the full story.